19 May 2023 - CODA Minerals Limited (ASX:COD) CEO and Executive Director Chris Stevens provides an overview of the company, discussing early successes, scoping study results and timeline.
02 Jun 2021 - Next Science Limited (ASX:NXS) Managing Director Judith Mitchell talks about the company's antimicrobial wound gel BlastX, and its health benefits for the treatment of chronic wounds and ulcers.
11 Apr 2023 - Lifestyle Communities Limited (ASX:LIC) CFO Darren Rowland provides an introduction to the company, discussing business model and service, market positioning and growth opportunities.
30 Jul 2024 - Jeffrey Schulze, Managing Director of ClearBridge Investments, shares insights on the US markets, discussing interest rates, catalysts for the rotation out of tech and the Magnificent Seven and the durability of the move into small caps.
10 May 2024 - Empire Energy Group's journey toward Beetaloo Basin production and its strategic moves, including asset sales and capital raises, shaping Australia's gas sector landscape.
16 Aug 2023 - Dr John Melki - CEO and Director - Genetic Signatures (ASX:GSS) is transforming molecular diagnostics via streamlined sample processing methods linked to highly multiplexed real-time PCR screening assays.
24 Feb 2022 - Shaw and Partners Chief Investment Officer Martin Crabb discusses the sectors to invest in given slowing global growth, tightening financial conditions, the risk of inflation and geopolitical imbalances.
22 Mar 2022 - Magnetite Mines Limited (ASX:MGT) Technical Director Mark Eames discusses the business case for further expansion of the Razorback Iron Ore Project in South Australia from three million tonnes per annum to seven million tonnes per annum.
28 Sep 2020 - Cyclopharm Limited (ASX:CYC) Managing Director and CEO James McBrayer provides an update on the company's US Phase 3 trial for Technegas, and USFDA approval process timeline, with commercial sales expected in the US for 2021.